TY  - GEN
AU  - Ocker,Matthias
TI  - Challenges and opportunities in drug development for nonalcoholic steatohepatitis
SN  - 1879-0712
PY  - 2020///1105
KW  - Animals
KW  - Biomarkers
KW  - Disease Progression
KW  - Drug Development
KW  - Fibrosis
KW  - complications
KW  - Humans
KW  - Incidence
KW  - Inflammation
KW  - Liver
KW  - metabolism
KW  - Liver Neoplasms
KW  - Metabolic Diseases
KW  - Non-alcoholic Fatty Liver Disease
KW  - drug therapy
KW  - Prevalence
KW  - Severity of Illness Index
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/j.ejphar.2020.172913
ER  -